No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 5.5x · 10Y median 5.3x · 69th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 8
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T11:05:29.639Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T11:05:29.639Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T11:05:29.639Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T11:05:29.639Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T11:05:29.639Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T11:05:29.639Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T11:05:29.639Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T11:05:29.639Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Aura Minerals (AUGO) stock was $85.17 as of Oct 5, 2026, 4:00 PM EDT, up 3.93% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +144.8%
Aura Minerals Inc. is a company primarily engaged in the production of gold and copper, focusing its efforts on developing and managing various gold and other base metal mining ventures throughout the Americas.
Gold · Coconut Grove, FL, FL
Next Earnings Date
Nov 5, 2026
30 days away
EPS Estimate
1.43
Revenue Est.
$359.81M
Last Quarter Results
EPS
$1.15
vs Estimate
$1.23
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AUGO | $7.14B | $85.17 | +3.93% | +144.78% | N/A | N/A | N/A |
| 2ACA | $7.21B | $146.75 | +0.17% | +58.85% | +23.73% | N/A | vs AUGO |
| 3MOS | $6.77B | $21.29 | +1.04% | -35.96% | -8.92% | +0.26% | vs AUGO |
| 4CTVA | $8.29B | $12.39 | +3.94% | -80.11% | -21.36% | N/A | vs AUGO |
| 5BLDR | $5.99B | $55.63 | -1.10% | -56.55% | +1.08% | +17.26% | vs AUGO |
| 6MP | $8.34B | $46.84 | -0.28% | -34.36% | +9.08% | N/A | vs AUGO |
TTM
5.54
$335.97M
vs Estimate
$335.49M
Consensus Rating
Based on 10 analysts
Average Price Target
$101.91
+19.7% upside
Low
$83.00
Current
$85.17
High
$122.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $1.17 | $1.43 | $1.68 | 1 |
| Quarter ending Dec 2026 | $1.59 | $1.67 | $1.73 | 1 |
| Quarter ending Mar 2027 | $1.59 | $1.67 | $1.72 | 1 |
| Quarter ending Jun 2027 | $1.81 | $1.90 | $1.96 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $6.38 | $7.01 | $8.10 | 4 |
| FY 2027 | $7.18 | $8.66 | $9.71 | 4 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $339.06M | $352.02M | $360.44M | 3 |
| Quarter ending Dec 2026 | $402.71M | $418.11M | $428.11M | 2 |
| Quarter ending Mar 2027 | $407.68M | $423.26M | $433.38M | 1 |
| Quarter ending Jun 2027 | $465.45M | $483.24M | $494.79M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $1.39B | $1.53B | $1.68B | 6 |
| FY 2027 | $1.65B | $1.82B | $2.01B | 6 |
